Development of collagen-poly(caprolactone)-based core-shell scaffolds supplemented with proteoglycans and glycosaminoglycans for ligament repair.

Collagen scaffolds Core-shell scaffolds Extracellular matrix components Ligament repair Mechanical properties Poly(caprolactone) fibers

Journal

Materials science & engineering. C, Materials for biological applications
ISSN: 1873-0191
Titre abrégé: Mater Sci Eng C Mater Biol Appl
Pays: Netherlands
ID NLM: 101484109

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 16 04 2020
revised: 01 10 2020
accepted: 16 10 2020
entrez: 6 2 2021
pubmed: 7 2 2021
medline: 15 5 2021
Statut: ppublish

Résumé

Core-shell scaffolds offer a promising regenerative solution to debilitating injuries to anterior cruciate ligament (ACL) thanks to a unique biphasic structure. Nevertheless, current core-shell designs are impaired by an imbalance between permeability, biochemical and mechanical cues. This study aimed to address this issue by creating a porous core-shell construct which favors cell infiltration and matrix production, while providing mechanical stability at the site of injury. The developed core-shell scaffold combines an outer shell of electrospun poly(caprolactone) fibers with a freeze-dried core of type I collagen doped with proteoglycans (biglycan, decorin) or glycosaminoglycans (chondroitin sulphate, dermatan sulphate). The aligned fibrous shell achieved an elastic modulus akin of the human ACL, while the porous collagen core is permeable to human mesenchymal stem cell (hMSC). Doping of the core with the aforementioned biomolecules led to structural and mechanical changes in the pore network. Assessment of cellular metabolic activity and scaffold contraction shows that hMSCs actively remodel the matrix at different degrees, depending on the core's doping formulation. Additionally, immunohistochemical staining and mRNA transcript levels show that the collagen-chondroitin sulphate formulation has the highest matrix production activity, while the collagen-decorin formulation featured a matrix production profile more characteristic of the undamaged tissue. Together, this demonstrates that scaffold doping with target biomolecules leads to distinct levels of cell-mediated matrix remodeling. Overall, this work resulted in the development of a versatile and robust platform with a combination of mechanical and biochemical features that have a significant potential in promoting the repair process of ACL tissue.

Identifiants

pubmed: 33545824
pii: S0928-4931(20)33575-X
doi: 10.1016/j.msec.2020.111657
pii:
doi:

Substances chimiques

Glycosaminoglycans 0
Polyesters 0
polycaprolactone 24980-41-4
Collagen 9007-34-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111657

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Pedro J Gouveia (PJ)

Tissue Engineering Research Group, Department of Anatomy & Regenerative Medicine, Royal College of Surgeons in Ireland (RCSI), Ireland; Advanced Materials and BioEngineering Research (AMBER) Centre, RCSI, Ireland.

Tom Hodgkinson (T)

Tissue Engineering Research Group, Department of Anatomy & Regenerative Medicine, Royal College of Surgeons in Ireland (RCSI), Ireland.

Isabel Amado (I)

Tissue Engineering Research Group, Department of Anatomy & Regenerative Medicine, Royal College of Surgeons in Ireland (RCSI), Ireland.

Joanna M Sadowska (JM)

Tissue Engineering Research Group, Department of Anatomy & Regenerative Medicine, Royal College of Surgeons in Ireland (RCSI), Ireland.

Alan J Ryan (AJ)

Tissue Engineering Research Group, Department of Anatomy & Regenerative Medicine, Royal College of Surgeons in Ireland (RCSI), Ireland; Advanced Materials and BioEngineering Research (AMBER) Centre, RCSI, Ireland.

Sara Romanazzo (S)

Trinity Centre for Biomedical Engineering, Trinity College Dublin (TCD), Ireland; Advanced Materials and BioEngineering Research (AMBER) Centre, RCSI, Ireland.

Simon Carroll (S)

Trinity Centre for Biomedical Engineering, Trinity College Dublin (TCD), Ireland; Advanced Materials and BioEngineering Research (AMBER) Centre, RCSI, Ireland.

Sally-Ann Cryan (SA)

School of Pharmacy & Biomolecular Sciences, RCSI, Ireland.

Daniel J Kelly (DJ)

Trinity Centre for Biomedical Engineering, Trinity College Dublin (TCD), Ireland; Advanced Materials and BioEngineering Research (AMBER) Centre, RCSI, Ireland.

Fergal J O'Brien (FJ)

Tissue Engineering Research Group, Department of Anatomy & Regenerative Medicine, Royal College of Surgeons in Ireland (RCSI), Ireland; Trinity Centre for Biomedical Engineering, Trinity College Dublin (TCD), Ireland; Advanced Materials and BioEngineering Research (AMBER) Centre, RCSI, Ireland. Electronic address: fjobrien@rcsi.ie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH